Sunovion Diversifies its Neurology Offerings with Acquisition of Cynapsus
By Jasmine Kalsi
Pharma Deals Review: Vol 2016 Issue 9 (Table of Contents)
Published: 13 Sep-2016
DOI: 10.3833/pdr.v2016.i9.2191 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
Expanding its CNS portfolio, Sumitomo Dainippon Pharma’s Sunovion Pharmaceuticals has agreed to acquire Canadian biotech Cynapsus Therapeutics for approximately US$624 M in cash...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS